Seeing Is Believing

Currently out of the existing stock ratings of Steve Silver, 3 are a BUY (100%).
Analyst Steve Silver, currently employed at ARGUS, carries an average stock price target met ratio of 33.33% that have a potential upside of 63.64% achieved within 278 days.
Steve Silver’s has documented 6 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on DXCM, DexCom at 03-Aug-2026.
Analyst best performing recommendations are on DXCM (DEXCOM).
The best stock recommendation documented was for DXCM (DEXCOM) at 11/7/2025. The price target of $90 was fulfilled within 278 days with a profit of $35 (63.64%) receiving and performance score of 2.29.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 10-Feb-2022
$95
$5.65 (6.32%)
$95
6 days ago
(17-Sep-2026)
6/10 (60%)
$5.65 (6.32%)
206
Buy Since 15-Jun-2025
$102
$12.65 (14.16%)
$93
6 days ago
(17-Sep-2026)
3/7 (42.86%)
$12.65 (14.16%)
152
Buy Since 20-Aug-2025
$96
$6.65 (7.44%)
$90
1 months 20 days ago
(03-Aug-2026)
1/3 (33.33%)
$9.06 (10.42%)
278
Buy Since 02-Feb-2022
$90
$0.65 (0.73%)
$85
1 months 24 days ago
(30-Jul-2026)
10/15 (66.67%)
$6.55 (7.85%)
160
Buy Since 01-Aug-2017
$88
$-1.35 (-1.51%)
$84
1 months 24 days ago
(30-Jul-2026)
25/33 (75.76%)
$4.55 (5.45%)
139
Which stock is Steve Silver most bullish on?
What Year was the first public recommendation made by Steve Silver?